Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'CONVERTING ENZYME-INHIBITOR' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 1094 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Nagel, N; Schweitzer, H; Urbach, H; Heyse, W; Muller, B; Berchtold, H
      Ramipril

      ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE
    2. Holst, DP; Kaye, D; Richardson, M; Krum, H; Prior, D; Aggarwal, A; Wolfe, R; Bergin, P
      Improved outcomes from a comprehensive management system for heart failure

      EUROPEAN JOURNAL OF HEART FAILURE
    3. Hurlen, M; Hole, T; Seljeflot, I; Arnesen, H
      Aspirin does not influence the effect of angiotensin-converting enzyme inhibition on left ventricular ejection fraction 3 months after acute myocardial infarction

      EUROPEAN JOURNAL OF HEART FAILURE
    4. McDonald, K; Ledwidge, M; Cahill, J; Kelly, J; Quigley, P; Maurer, B; Begley, F; Ryder, M; Travers, B; Timmons, L; Burke, T
      Elimination of early rehospitalization in a randomized, controlled trial of multidisciplinary care in a high-risk, elderly heart failure population: the potential contributions of specialist care, clinical stability and optimal angiotensin-converting enzyme inhibitor dose at discharge

      EUROPEAN JOURNAL OF HEART FAILURE
    5. Prieto, JA; Jimenez, RM; Alonso, RM; Ortiz, E
      Determination of the antihypertensive drug cilazapril and its active metabolite cilazaprilat in pharmaceuticals and urine by solid-phase extraction and high-performance liquid chromatography with photometric detection

      JOURNAL OF CHROMATOGRAPHY B
    6. Junot, C; Pruvost, A; Creminon, C; Grognet, JM; Benech, H; Ezan, E
      Characterization of immunoreactive acetyl-Ser-Asp-Lys-Pro in human plasma and urine by liquid chromatography-electrospray mass spectrometry

      JOURNAL OF CHROMATOGRAPHY B
    7. Ohishi, T; Saito, H; Tsusaka, K; Toda, K; Inagaki, H; Hamada, Y; Kumagai, N; Atsukawa, K; Ishii, H
      Anti-fibrogenic effect of an angiotensin converting enzyme inhibitor on chronic carbon tetrachloride-induced hepatic fibrosis in rats

      HEPATOLOGY RESEARCH
    8. Lasko, BH; Laplante, A; Hebert, D; Bonnefis-Boyer, S
      Canadian valsartan study in patients with mild-to-moderate hypertension

      BLOOD PRESSURE MONITORING
    9. Neutel, JM
      The importance of 24-h blood pressure control

      BLOOD PRESSURE MONITORING
    10. du Toit, E; Hofmann, D; McCarthy, J; Pineda, C
      Effect of levosimendan on myocardial contractility, coronary and peripheral blood flow, and arrhythmias during coronary artery ligation and reperfusion in the in vivo pig model

      HEART
    11. Malik, IS; Bhatia, VK; Kooner, JS
      Cost effectiveness of ramipril treatment for cardiovascular risk reduction

      HEART
    12. Doggrell, SA; Brown, L
      The spironolactone renaissance

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    13. Hadjadj, S; Torremocha, F; Fanelli, A; Brizard, A; Bauwens, M; Marechaud, R
      Erythropoietin-dependent anaemia: A possible complication of diabetic neuropathy

      DIABETES & METABOLISM
    14. Lupo, A; Marcantoni, C; Bernich, P; Maschio, G
      Resolution of renal disease: mission impossible?

      JOURNAL OF NEPHROLOGY
    15. Anderson, WG; Cerra, MC; Wells, A; Tierney, ML; Tota, B; Takei, Y; Hazon, N
      Angiotensin and angiotensin receptors in cartilaginous fishes

      COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY A-MOLECULAR AND INTEGRATIVE PHYSIOLOGY
    16. Borgarelli, M; Tarducci, A; Tidholm, A; Haggstrom, J
      Canine idiopathic dilated cardiomyopathy. Part II: Pathophysiology and therapy

      VETERINARY JOURNAL
    17. Joy, MS
      Novel erythropoiesis-stimulating protein - An erythropoietin analogue withan extended half-life and less frequent dosing

      FORMULARY
    18. Crook, ED; Harris, J; Oliver, B; Fleischman, E; Crenshaw, G; Taylor, R
      Endstage renal disease owing to diabetic nephropathy in Mississippi: An examination of factors influencing renal survival in a population prone to late referral

      JOURNAL OF INVESTIGATIVE MEDICINE
    19. Dauterman, KW; Go, AS; Rowell, R; Gebretsadik, T; Gettner, S; Massie, BM
      Congestive heart failure with preserved systolic function in a statewide sample of community hospitals

      JOURNAL OF CARDIAC FAILURE
    20. Watanabe, K; Sekiya, M; Tsuruoka, T; Funada, JI; Miyagawa, M
      Usefulness of I-123-BMIPP with myocardial imaging for evaluation of the efficacy of drug therapy in patients with chronic heart failure

      JOURNAL OF CARDIAC FAILURE
    21. Berman, DS; Kang, XP; Schisterman, EF; Gerlach, J; Kavanagh, PB; Areeda, JS; Sharir, T; Hayes, SW; Shaw, LJ; Lewin, HC; Friedman, JD; Miranda, R; Germano, G
      Serial changes on quantitative myocardial perfusion SPECT in patients undergoing revascularization or conservative therapy

      JOURNAL OF NUCLEAR CARDIOLOGY
    22. Suzuki, H; Saruta, T
      Effects of calcium antagonist, benidipine, on the progression of chronic renal failure in the elderly: A 1-year follow-up

      CLINICAL AND EXPERIMENTAL HYPERTENSION
    23. Struckman, DR; Rivey, MP
      Combined therapy with an angiotensin II receptor blocker and an angiotensin-converting enzyme inhibitor in heart failure

      ANNALS OF PHARMACOTHERAPY
    24. Dillon, JJ
      Treating IgA nephropathy

      JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
    25. Hickling, JA; Nazareth, I; Rogers, S
      The barriers to effective management of heart failure in general practice

      BRITISH JOURNAL OF GENERAL PRACTICE
    26. Poulsen, PL; Ebbehoj, E; Mogensen, CE
      Lisinopril reduces albuminuria during exercise in low grade microalbuminuric type 1 diabetic patients: a double blind randomized study

      JOURNAL OF INTERNAL MEDICINE
    27. Fagard, R; Lijnen, P; Pardaens, K; Thijs, L; Vinck, W
      A randomised, placebo-controlled, double-blind, crossover study of losartan and enalapril in patients with essential hypertension

      JOURNAL OF HUMAN HYPERTENSION
    28. Bakris, GL
      Treatment of stage I hypertension and development of renal dysfunction

      JOURNAL OF HUMAN HYPERTENSION
    29. Ohnishi, K; Kohno, M; Yukiiri, K; Masugata, H; Wada, Y; Takagi, Y; Ohmori, K
      Influence of the angiotensin II receptor antagonist losartan on diuretic-induced metabolic effects in elderly hypertensive patients: comparison with a calcium channel blocker

      INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
    30. Orth, SR; Ritz, E
      Specific organ protection by blocking the renin-angiotensin system

      NEPHROLOGY DIALYSIS TRANSPLANTATION
    31. Zawaideh, MA; Duncan, B; Joseph, MW; Dixit, MP
      Treatment of chronic hypertension with intravenous enalaprilat and transdermal clonidine

      PEDIATRIC NEPHROLOGY
    32. Bouvy, ML; Heerdink, ER; Herings, RMC
      Long term therapy with spironolactone

      PHARMACY WORLD & SCIENCE
    33. Di Pasquale, P; Cannizzaro, S; Scandurra, A; Giubilato, A; Scalzo, S; Paterna, S
      ACE-inhibition plus mineralocorticoid antagonism versus ACE-inhibition alone in patients with anterior myocardial infarction

      CARDIOVASCULAR DRUGS AND THERAPY
    34. Pitt, B; Williams, G; Remme, W; Martinez, F; Lopez-Sendon, J; Zannad, F; Neaton, J; Roniker, B; Hurley, S; Burns, D; Bittman, R; Kleiman, J
      The EPHESUS trial: Eplerenone in patients with heart failure due to systolic dysfunction complicating acute myocardial infarction

      CARDIOVASCULAR DRUGS AND THERAPY
    35. Epstein, M
      Aldosterone as a mediator of progressive renal dysfunction: Evolving perspectives

      INTERNAL MEDICINE
    36. Kojima, S; Shida, M; Takano, H; Inami, S; Yodogawa, K; Yokoyama, H; Kuramochi, M
      Effects of losartan on blood pressure and humoral factors in a patient whosuffered from anaphylactoid reactions when treated with ACE inhibitors during LDL apheresis

      Hypertension research
    37. Kawabata, H; Ryomoto, T; Ishikawa, K
      Cardioprotection with angiotensin converting enzyme inhibitor and angiotensin II type I receptor antagonist is not abolished by nitric oxide synthaseinhibitor in ischemia-reperfused rabbit hearts

      Hypertension research
    38. Miyazaki, MA; Takai, S
      Local angiotensin II-generating system in vascular tissues: The roles of chymase

      Hypertension research
    39. Shionoiri, H; Takasaki, I; Minamisawa, K; Ishizuka, H; Konno, K; Naganuma, H; Sasahara, K; Kawahara, Y
      Trandolaprilat, an angiotensin-converting enzyme inhibitor, is not excreted in bile via an ATP-dependent active transporter (cMOAT)

      Hypertension research
    40. Sato, A; Takane, H; Saruta, T
      High serum level of procollagen type III amino-terminal peptide contributes to the efficacy of spironolactone and angiotensin-converting enzyme inhibitor therapy on left ventricular hypertrophy in essential hypertensive patients

      Hypertension research
    41. Galatius, S
      Impact of microvascular alterations in heart failure Effect of cardiac transplantation and ACE inhibition

      DANISH MEDICAL BULLETIN
    42. Midtvedt, K; Hartmann, A; Holdaas, H; Fauchald, P
      Efficacy of nifedipine or lisinopril in the treatment of hypertension after renal transplantation: a double-blind randomised comparative trial

      CLINICAL TRANSPLANTATION
    43. Laragh, J
      Laragh's lessons in pathophysiology and clinical pearls for treating hypertension

      AMERICAN JOURNAL OF HYPERTENSION
    44. Fogari, R; Zoppi, A; Preti, P; Fogari, E; Malamani, G; Mugellini, A
      Differential effects of ACE-inhibition and angiotensin II antagonism on fibrinolysis and insulin sensitivity in hypertensive postmenopausal women

      AMERICAN JOURNAL OF HYPERTENSION
    45. Dart, AM; Reid, CM; McGrath, B
      Effects of ACE inhibitor therapy on derived central arterial waveforms in hypertension

      AMERICAN JOURNAL OF HYPERTENSION
    46. Crook, ED
      Diabetic nephropathy in African Americans

      AMERICAN JOURNAL OF HYPERTENSION
    47. Masuo, K; Mikami, H; Ogihara, T; Tuck, ML
      Weight reduction and pharmacologic treatment in obese hypertensives

      AMERICAN JOURNAL OF HYPERTENSION
    48. Mann, SJ; Gerber, LM
      Low-dose alpha/beta blockade in the treatment of essential hypertension

      AMERICAN JOURNAL OF HYPERTENSION
    49. Weir, MR; Weber, MA; Neutel, JM; Vendetti, J; Michelson, EL; Wang, RY
      Efficacy of candesartan cilexetil as add-on therapy in hypertensive patients uncontrolled on background therapy: A clinical experience trial

      AMERICAN JOURNAL OF HYPERTENSION
    50. Neutel, JM
      New blood pressure goals: The importance of combination therapy - Introduction

      AMERICAN JOURNAL OF HYPERTENSION
    51. Hara, K; Kobayashi, N; Watanabe, S; Tsubokou, Y; Matsuoka, H
      Effects of quinapril on expression of eNOS, ACE, and AT1 receptor in deoxycorticosterone acetate-salt hypertensive rats

      AMERICAN JOURNAL OF HYPERTENSION
    52. Blumenfeld, JD; Laragh, JH
      Management of hypertensive crises: The scientific basis for treatment decisions

      AMERICAN JOURNAL OF HYPERTENSION
    53. Opie, LH
      Calcium channel blockers in hypertension: Reappraisal after new trials andmajor meta-analyses

      AMERICAN JOURNAL OF HYPERTENSION
    54. Blezer, ELA; Nicolay, K; Koomans, HA; Joles, JA
      Losartan versus enalapril on cerebral edema and proteinuria in stroke-prone hypertensive rats

      AMERICAN JOURNAL OF HYPERTENSION
    55. Laragh, J
      Laragh's lessons in pathophysiology and clinical pearls for treating hypertension

      AMERICAN JOURNAL OF HYPERTENSION
    56. Ozkan, M; Dweik, RA; Ahmad, M
      Drug-induced lung disease

      CLEVELAND CLINIC JOURNAL OF MEDICINE
    57. Giannetti, N
      Management of congestive heart failure: How well are we doing?

      CANADIAN MEDICAL ASSOCIATION JOURNAL
    58. Nicholls, MG; Lainchbury, JG; Richards, AM; Troughton, RW; Yandle, TG
      Brain natriuretic peptide-guided therapy for heart failure

      ANNALS OF MEDICINE
    59. Jones, SC; Bowes, PD; Hall, E; Connolly, V; Kelly, WF; Bilous, RW
      HOPE for patients with Type 2 diabetes: an application of the findings of the MICRO-HOPE substudy in a British hospital diabetes clinic

      DIABETIC MEDICINE
    60. Yee, KM; Pringle, SD; Struthers, AD
      Circadian variation in the effects of aldosterone blockade on heart rate variability and QT dispersion in congestive heart failure

      JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    61. Kjoller-Hansen, L; Steffensen, R; Grande, P
      Beneficial effects of ramipril on left ventricular end-diastolic and end-systolic volume indexes after uncomplicated invasive revascularization are associated with a reduction in cardiac events in patients with moderately impaired left ventricular function and no clinical heart failure

      JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    62. Al-Omari, MM; Abdelah, MK; Badwan, AA; Jaber, AMY
      Effect of the drug-matrix on the stability of enalapril maleate in tablet formulations

      JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
    63. Cai, X; Shen, WF; Gong, LS
      Relationship between age and effect of early and long-term captopril treatment in patients with acute myocardial infarction

      CHINESE MEDICAL JOURNAL
    64. Kaminaga, T; Matsumura, K; Hatanaka, H; Shimizu, T
      Abnormality of the myocardial sympathetic nervous system in a patient withbecker muscular dystrophy detected with iodine-123 metaiodobenzylguanidinescintigraphy

      CLINICAL NUCLEAR MEDICINE
    65. Taal, MW; Chertow, GM; Rennke, HG; Gurnani, A; Jiang, T; Shahsafaei, A; Troy, JL; Brenner, BM; Mackenzie, HS
      Mechanisms underlying renoprotection during renin-angiotensin system blockade

      AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY
    66. Campbell, DJ; Dixon, B; Kladis, A; Kemme, M; Santamaria, JD
      Activation of the kallikrein-kinin system by cardiopulmonary bypass in humans

      AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
    67. De Backer, AI; De Schepper, AM; Vendevenne, JE; Schoeters, P; Michielsen, P; Stevens, WJ
      Original report. CT of angioedema of the small bowel.

      AMERICAN JOURNAL OF ROENTGENOLOGY
    68. McIntyre, CW; Fluck, RJ; Lambie, SH
      Steroid and cyclophosphamide therapy for IgA nephropathy associated with crescenteric change: An effective treatment

      CLINICAL NEPHROLOGY
    69. Nishimura, M; Sasaki, T; Ohishi, A; Oishi, M; Kono, S; Totani, Y; Kato, Y; Noto, Y; Misaki, S; Higashi, K; Shimada, F; Wakasugi, H; Inoue, K; Hoshiyama, Y; Yamada, K
      Angiotensin-converting enzyme inhibitors and probucol suppress the time-dependent increase in urinary Type IV collagen excretion of Type II diabetes mellitus patients with early diabetic nephropathy

      CLINICAL NEPHROLOGY
    70. Usta, M; Dilek, K; Yavuz, M; Ersoy, A; Gullulu, M; Yurtkuran, M
      Anti-proteinuric effect of angiotension II receptor antagonist losartan incases with glomerular lesions

      CLINICAL NEPHROLOGY
    71. Escasany, AA; Dalmau, MD; de Bolos, JMA; Cumplido, DR; Fadini, ED; Rodriguez, JC; Basilio, EG; Lorite, NM
      Evidence based treatment of heart failure

      REVISTA ESPANOLA DE CARDIOLOGIA
    72. van der Does, R; Euler, R
      A randomized, double-blind, parallel-group study to compare the anti-hypertensive effects of imidapril and nifedipine in the treatment of mild-to-moderate essential hypertension

      JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
    73. Dews, I; VandenBurg, M
      A 24-week dose-titration study of the angiotensin-converting enzyme inhibitor imidapril in the treatment of mild-to-moderate essential hypertension in the elderly

      JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
    74. Sato, A; Saruta, T
      Aldosterone escape during angiotensin-converting enzyme inhibitor therapy in essential hypertensive patients with left ventricular hypertrophy

      JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
    75. Kendrick, E
      Cardiovascular disease and the renal transplant recipient

      AMERICAN JOURNAL OF KIDNEY DISEASES
    76. Taal, MW; Brenner, BM
      Achieving maximal renal protection in nondiabetic chronic renal disease

      AMERICAN JOURNAL OF KIDNEY DISEASES
    77. Keane, WF
      Metabolic pathogenesis of cardiorenal disease

      AMERICAN JOURNAL OF KIDNEY DISEASES
    78. Reddan, DN; Owen, WF
      IgA nephropathy and inhibitors of the renin angiotensin system: Is reduction in proteinuria adequate proof of efficacy?

      AMERICAN JOURNAL OF KIDNEY DISEASES
    79. Epstein, M
      Aldosterone as a mediator of progressive renal disease: Pathogenetic and clinical implications

      AMERICAN JOURNAL OF KIDNEY DISEASES
    80. Shiigai, T; Shichiri, M
      Late escape from the antiproteinuric effect of ACE inhibitors in nondiabetic renal disease

      AMERICAN JOURNAL OF KIDNEY DISEASES
    81. Fujita, H; Yamagami, T; Ohshima, K
      Effects of an ace-inhibitory agent, Katsuobushi oligopeptide, in the spontaneously hypertensive rat and in borderline and mildly hypertensive subjects

      NUTRITION RESEARCH
    82. Warnock, DG
      Prevention, protection, and the intrarenal renin-angiotensin systems

      SEMINARS IN NEPHROLOGY
    83. Katovich, MJ; Reaves, PY; Francis, SC; Pachori, AS; Wang, HW; Raizada, MK
      Gene therapy attenuates the elevated blood pressure and glucose intolerance in an insulin-resistant model of hypertension

      JOURNAL OF HYPERTENSION
    84. Paull, JRA; Widdop, RE
      Persistent cardiovascular effects of chronic renin-angiotensin system inhibition following withdrawal in adult spontaneously hypertensive rats

      JOURNAL OF HYPERTENSION
    85. Sever, PS; Dahlof, B; Poulter, NR; Wedel, H; Beevers, G; Caulfield, M; Collins, R; Kjeldsen, SE; McInnes, GT; Mehlsen, J; Nieminen, M; O'Brien, E; Ostergren, J
      Rationale, design, methods and baseline demography of participants of the Anglo-Scandinavian cardiac outcomes trial

      JOURNAL OF HYPERTENSION
    86. Park, JB; Schiffrin, EL
      Small artery remodeling is the most prevalent (earliest?) form of target organ damage in mild essential hypertension

      JOURNAL OF HYPERTENSION
    87. Waeber, B; Aschwanden, R; Sadecky, L; Ferber, P
      Combination of hydrochlorothiazide or benazepril with valsartan in hypertensive patients unresponsive to valsartan alone

      JOURNAL OF HYPERTENSION
    88. Raji, A; Williams, GH; Jeunemaitre, X; Hopkins, PN; Hunt, SC; Hollenberg, NK; Seely, EW
      Insulin resistance in hypertensives: effect of salt sensitivity, renin status and sodium intake

      JOURNAL OF HYPERTENSION
    89. de Leeuw, PW
      Very-low-dose combination of perindopril and indapamide as a novel strategy in first-line management of hypertension

      JOURNAL OF HYPERTENSION
    90. Remme, WJ; Swedberg, K
      Guidelines for the diagnosis and treatment of chronic heart failure

      EUROPEAN HEART JOURNAL
    91. Asmar, RG; London, GM; O'Rourke, ME; Safar, ME
      Improvement in blood pressure, arterial stiffness and wave reflections with a very-low-dose perindopril/indapamide combination in hypertensive patient - A comparison with atenolol

      HYPERTENSION
    92. Sanada, S; Kitakaze, M; Node, K; Takashima, S; Ogai, A; Asanuma, H; Sakata, Y; Asakura, M; Ogita, H; Liao, YL; Fukushima, T; Yamada, J; Minamino, T; Kuzuya, T; Hori, M
      Differential subcellular actions of ACE inhibitors and AT(1) receptor antagonists on cardiac remodeling induced by chronic inhibition of NO synthesisin rats

      HYPERTENSION
    93. Leenen, FHH; Yuan, BX
      Prevention of hypertension by irbesartan in Dahl S rats relates to centralangiotensin II type 1 receptor blockade

      HYPERTENSION
    94. Kintscher, U; Wakino, S; Kim, S; Fleck, E; Hsueh, WA; Law, RE
      Angiotensin II induces migration and Pyk2/paxillin phosphorylation of human monocytes

      HYPERTENSION
    95. Williams, SG; Cooke, GA; Wright, DJ; Tan, LB
      Disparate results of ACE inhibitor dosage on exercise capacity in heart failure: a reappraisal of vasodilator therapy and study design

      INTERNATIONAL JOURNAL OF CARDIOLOGY
    96. Levine, TB; Levine, AB; Elliott, WG; Narins, B; Stomel, RJ
      Dobutamine as bridge to angiotensin-converting enzyme inhibitor-nitrate therapy in endstage heart failure

      CLINICAL CARDIOLOGY
    97. Megnien, JL; Simon, A; Mikaberidze, E; Denarie, N; Chironi, G; Barra, J; Armentano, R; Levenson, J
      Do arterial effects of antihypertensive drugs depend on subject's serum cholesterol?

      JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    98. Delles, C; Schmieder, RE
      The kidney in congestive heart failure: Renal adverse event rate of treatment

      JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    99. Ma, ML; Watanabe, K; Wahed, MII; Inoue, M; Sekiguchi, T; Kouda, T; Ohta, Y; Nakazawa, M; Yoshida, Y; Yamamoto, T; Hanawa, H; Kodama, M; Fuse, K; Aizawa, Y
      Inhibition of progression of heart failure and expression of TGF-beta 1 mRNA in rats with heart failure by the ACE inhibitor quinapril

      JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    100. Ohta, T; Hasebe, N; Tsuji, S; Jin, YT; Kido, S; Natori, S; Sato, M; Kikuchi, K
      Effects of angiotensin converting enzyme inhibitor and angiotensin II type1 receptor blocker on cardiac dysfunction induced by isoproterenol in dogs

      JOURNAL OF CARDIOVASCULAR PHARMACOLOGY


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 05/08/20 alle ore 17:53:54